14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

Aptose Biosciences Stock Forecast

NASDAQ:APTO BUY SELL

$1.05 (0%)

Volume: 244.642k

Closed: May 19, 2022

Hollow Logo Score: -3.475

Aptose Biosciences Stock Forecast

BUY SELL NASDAQ:APTO
$1.05 (0%)

Volume: 244.642k

Closed: May 19, 2022

Score Hollow Logo -3.475

Aptose Biosciences Stock Forecast NASDAQ:APTO

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-10 471.43% RBC Capital $7.00 $6.00 Maintains Outperform
2021-12-21 1042.86% HC Wainwright & Co. $14.00 $12.00 Maintains Buy
2021-11-12 1233.33% HC Wainwright & Co. $9.00 $14.00 Maintains Buy
2021-03-24 757.14% Oppenheimer $8.00 $9.00 Maintains Outperform
2020-02-20 1423.81% Maxim Group $16.00 Initiates Coverage On Buy
2020-01-09 852.38% Piper Sandler $10.00 Initiates Coverage On Overweight
2019-08-07 471.43% HC Wainwright & Co. $8.50 $6.00 Reiterates Buy

APTO Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -3.62% during the next 3 months and, with a 90% probability hold a price between $0.91 and $1.39 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-23 $0.94 $1.19 $1.44
2022-05-24 $0.94 $1.19 $1.44
2022-05-25 $0.94 $1.19 $1.44
2022-05-26 $0.94 $1.19 $1.44
2022-05-27 $0.94 $1.19 $1.44
2022-05-31 $0.94 $1.19 $1.44
2022-06-01 $0.94 $1.19 $1.44
2022-06-02 $0.94 $1.19 $1.43
2022-06-03 $0.94 $1.19 $1.43
2022-06-06 $0.94 $1.18 $1.43
2022-06-07 $0.94 $1.18 $1.43
2022-06-08 $0.93 $1.18 $1.43
2022-06-09 $0.93 $1.18 $1.43
2022-06-10 $0.93 $1.18 $1.43
2022-06-13 $0.93 $1.18 $1.43
2022-06-14 $0.93 $1.18 $1.43
2022-06-15 $0.93 $1.18 $1.43
2022-06-16 $0.93 $1.18 $1.43
2022-06-17 $0.93 $1.18 $1.42
2022-06-21 $0.93 $1.18 $1.42
2022-06-22 $0.93 $1.17 $1.42
2022-06-23 $0.93 $1.17 $1.42
2022-06-24 $0.93 $1.17 $1.42
2022-06-27 $0.92 $1.17 $1.42
2022-06-28 $0.92 $1.17 $1.42
2022-06-29 $0.92 $1.17 $1.42
2022-06-30 $0.92 $1.17 $1.42
2022-07-01 $0.92 $1.17 $1.42
2022-07-05 $0.92 $1.17 $1.42
2022-07-06 $0.92 $1.17 $1.41

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, a small molecule that induces the transcription of the Krüppel-like factor 4 Gene in in vitro studies and in in vivo pharmacodynamic studies of human xenograft tumors in mice. The company’s APTO-253 clinical program has completed Phase-I clinic... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT